Hepatitis B Reactivation in a Patient Receiving Chemotherapy for Breast Cancer: A Case Report

被引：4
作者：
Remo, Mylene [1 ]
Abraham, Ivy [1 ]
Kankanala, Vineel [2 ]
Chacra, Wadih [2 ]
Danciu, Oana C. [1 ]
机构：
[1] Univ Illinois, Coll Med, Div Hematol Oncol, 840 South Wood St,Room 832,MC 713, Chicago, IL 60612 USA
[2] Univ Illinois, Coll Med, Div Gastroenterol & Hepatol, Chicago, IL USA
来源：
ANTICANCER RESEARCH | 2017年 / 37卷 / 07期
关键词：
Breast cancer; chemotherapy; hepatitis B; liver failure; screening; VIRUS REACTIVATION; MANAGEMENT; PREVENTION;
D O I：
10.21873/anticanres.11755
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Hepatitis B virus (HBV) reactivation is a known complication of immunosuppressive therapy. While patients who are undergoing treatment with anti-CD20 agents or stem cell transplantation are commonly screened for chronic HBV infection prior to treatment, there are no consensus guidelines regarding HBV screening for patients undergoing chemotherapy for solid tumors. We present a rare case of fulminant liver failure due to HBV reactivation in a patient receiving chemotherapy for breast cancer. Our case highlights the importance of developing definitive guidelines regarding HBV screening in patients receiving chemotherapy for solid tumors and raises the question of the need for universal screening.
引用
收藏
页码：3791 / 3793
页数：3
相关论文
共 15 条
  • [1] [Anonymous], VIR HEP STAT SURV
  • [2] Prevalence of hepatitis B and C and sensibility of a selective screening questionnaire in patients receiving chemotherapy for solid tumors
    Brasseur, Mathilde
    Heurgue-Berlot, Alexandra
    Barbe, Coralie
    Brami, Cloe
    Rey, Jean-Baptiste
    Vella-Boucaud, Juliette
    Dabouz, Fadia
    Deslee, Gaetan
    Grange, Florent
    Volet, Julien
    Bouche, Olivier
    [J]. BMC CANCER, 2015, 15
  • [3] Prevention and management of hepatitis B virus reactivation in cancer patients
    Cheung, Ka-Shing
    Seto, Wai-Kay
    Lai, Ching-Lung
    Yuen, Man-Fung
    [J]. HEPATOLOGY INTERNATIONAL, 2016, 10 (03) : 407 - 414
  • [4] Recent US Food and Drug Administration Warnings on Hepatitis B Reactivation With Immune-Suppressing and Anticancer Drugs: Just the Tip of the Iceberg?
    Di Bisceglie, Adrian M.
    Lok, Anna S.
    Martin, Paul
    Terrault, Norah
    Perrillo, Robert P.
    Hoofnagle, Jay H.
    [J]. HEPATOLOGY, 2015, 61 (02) : 703 - 711
  • [5] Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update
    Hwang, Jessica P.
    Somerfield, Mark R.
    Alston-Johnson, Devena E.
    Cryer, Donna R.
    Feld, Jordan J.
    Kramer, Barnett S.
    Sabichi, Anita L.
    Wong, Sandra L.
    Artz, Andrew S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (19) : 2212 - U128
  • [6] Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center
    Hwang, Jessica P.
    Fisch, Michael J.
    Lok, Anna S-F
    Zhang, Hong
    Vierling, John M.
    Suarez-Almazor, Maria E.
    [J]. BMC CANCER, 2013, 13
  • [7] Hepatitis B virus reactivation in adjuvant chemotherapy for breast cancer
    Ide, Yoshimi
    Ito, Yoshinori
    Takahashi, Shunji
    Tokudome, Nahomi
    Kobayashi, Kokoro
    Sugihara, Tsutomu
    Hattori, Masaya
    Yokoyama, Masahiro
    Uchiyama, Akira
    Inoue, Kazuaki
    Sakurai, Norio
    Hatake, Kiyohiko
    [J]. BREAST CANCER, 2013, 20 (04) : 367 - 370
  • [8] Hepatitis B virus reactivation risk varies with different chemotherapy regimens commonly used in solid tumours
    Ling, W. H. Y.
    Soe, P. P.
    Pang, A. S. L.
    Lee, S-C
    [J]. BRITISH JOURNAL OF CANCER, 2013, 108 (10) : 1931 - 1935
  • [9] Evaluating Hepatitis B Virus Reactivation During Solid Tumor Chemotherapy: Evidence to Guide Pretreatment Hepatitis B Screening and Prophylaxis
    Lo Re, Vincent, III
    Schuster, Mindy
    [J]. ANNALS OF INTERNAL MEDICINE, 2016, 164 (01) : 64 - +
  • [10] Ludwig E, 2015, ONCOLOGY-NY, V29, P937
12